Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP3 | Q9NSD7 | 16/20 | 0.84 |
| ▸ | GAA | P10253 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.60 |
| ▸ | HTR1A | P08908 | 1/20 | 0.57 |
| ▸ | HTR1D | P28221 | 1/20 | 0.57 |
| ▸ | HTR2C | P28335 | 1/20 | 0.57 |
| ▸ | NPC1 | O15118 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4700992 | 0.83 | RXFP3 (0.66) | RXFP3GAAMAPTCYP1A2CYP3A4 | |
| SCHEMBL4699822 | 0.81 | MAPT (0.63) | RXFP3GAAMAPTCYP1A2CYP3A4 | |
| SCHEMBL4701251 | 0.77 | RAB9A (0.55) | RXFP3GAAMAPTCYP1A2CYP3A4 | |
| SCHEMBL4698350 | 0.77 | MAPT (0.67) | RXFP3GAAMAPTCYP1A2CYP3A4 | |
| SCHEMBL4697181 | 0.77 | RXFP3 (0.52) | RXFP3GAAMAPTCYP1A2CYP3A4 | |
| SCHEMBL4332218 | 0.76 | MAPT (1.00) | GAAMAPTCYP1A2CYP3A4NPC1 | |
| SCHEMBL8257172 | 0.76 | MAPT (0.74) | GAAMAPTCYP1A2CYP3A4NPC1 | |
| SCHEMBL7623116 | 0.76 | MAPT (0.74) | GAAMAPTCYP1A2CYP3A4NPC1 | |
| SCHEMBL7623120 | 0.76 | MAPT (0.74) | GAAMAPTCYP1A2CYP3A4NPC1 | |
| SCHEMBL4332222 | 0.76 | MAPT (1.00) | GAAMAPTCYP1A2CYP3A4NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7153881-B2 | Compounds acting as melanocortin receptor ligands | ACURE PHARMA AB (SE) | 2006-12-26 | — | — | US | claimed |
| EP-1309544-B1 | COMPOUNDS ACTING AS MELANOCORTIN RECEPTOR LIGANDS | ACURE PHARMA AB (SE) | 2008-11-05 | — | — | EP | disclosed |
| US-7153881-B2 | Compounds acting as melanocortin receptor ligands | ACURE PHARMA AB (SE) | 2006-12-26 | — | — | US | disclosed |